Tower Research Capital (TRC)
BRTX icon

Tower Research Capital (TRC)’s BioRestorative Therapies BRTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$550 Hold
73
– – ﹤0.01% 4998
2026
Q1 		$398 Buy
73
+18
+33% +$231 ﹤0.01% 4884
2025
Q4 		$1.3K Sell
55
-126
-70% -$3.35K ﹤0.01% 4720
2025
Q3 		$5.25K Buy
181
+117
+183% +$3.62K ﹤0.01% 4254
2025
Q2 		$2.13K Sell
64
-96
-60% -$3.34K ﹤0.01% 4693
2025
Q1 		$5.69K Buy
160
+81
+103% +$3.1K ﹤0.01% 4095
2024
Q4 		$2.25K Sell
79
-29
-27% -$898 ﹤0.01% 4880
2024
Q3 		$3.74K Sell
108
-132
-55% -$4.35K ﹤0.01% 4779
2024
Q2 		$9.73K Buy
240
+107
+80% +$3.08K ﹤0.01% 4213
2024
Q1 		$3.67K Buy
133
+91
+217% +$2.8K ﹤0.01% 4821
2023
Q4 		$1.47K Buy
+42
New +$1.6K ﹤0.01% 5376
2023
Q3 		– Sell
-37
Closed -$3.26K – 5960
2023
Q2 		$3.26K Sell
37
-24
-39% -$2.3K ﹤0.01% 5092
2023
Q1 		$4K Sell
61
-148
-71% -$9.08K ﹤0.01% 5049
2022
Q4 		$11K Buy
209
+96
+85% +$5.98K ﹤0.01% 3791
2022
Q3 		$7K Sell
113
-5
-4% -$311 ﹤0.01% 4870
2022
Q2 		$7K Buy
118
+71
+151% +$6.02K ﹤0.01% 4765
2022
Q1 		$5K Buy
+47
New +$4.06K ﹤0.01% 5022

Other funds holding BRTX

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

Tower Research Capital (TRC)'s BRTX Position: Q2 2026 in Review

Tower Research Capital (TRC) held its BioRestorative Therapies (BRTX) position steady in Q2 2026 at 73 shares worth $550. The position accounts for ﹤0.01% of the portfolio, ranked #4998.

Tower Research Capital (TRC) first reported a position in BRTX in Q1 2022 and has held it in 17 quarters since. The position peaked at $11K in Q4 2022. 18 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

  • Tower Research Capital (TRC) held 73 shares of BioRestorative Therapies worth $550 as of Q2 2026.
  • Tower Research Capital (TRC) left its BioRestorative Therapies share count unchanged in Q2 2026.
  • BioRestorative Therapies made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4998 holding.
  • Tower Research Capital (TRC) first reported a position in BioRestorative Therapies in Q1 2022 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s BioRestorative Therapies position peaked at $11K in Q4 2022.
  • 18 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.